期刊文献+

2-苯氧茚酮类乙酰胆碱酯酶抑制剂的3D-QSAR研究(英文) 被引量:4

3D-QSAR studies on AChE inhibitory activities of 2-phenoxy-indan-1-one derivatives
下载PDF
导出
摘要 目的研究2-苯氧茚酮类乙酰胆碱酯酶抑制剂的三维定量构效关系。方法采用比较分子力场分析法(CoMFA)和比较分子相似性指数分析法(CoMSIA)对结构与活性的关系进行研究。结果CoMFA模型表明立体场和静电场对活性的贡献分别为0.805和0.195;CoMSIA模型阐明疏水场和氢键场对活性也有一定的影响。结论两种3D-QSAR模型都显示出相当高的预测能力,CoMFA和CoMSIA的交叉验证值q2分别为0.881和0.918,通过对两种3D-QSAR模型等势图的分析,可为开展进一步的药物设计和结构优化提供理论指导和依据。 Aim To study the 3D-QSAR of 2-phenoxy-indan-1-one derivatives bearing AChE inhibitory activities. Methods Comparative molecular field analysis (CoMFA) and comparative molecular similarity indices analysis (CoMSIA) were used. Results The results show that the contributions of steric and electrostatic fields to the activity with CoMFA model are 0. 805 and 0.195, respectively. Addition of CoMSIA study has elucidated the role of hydrophobic and hydrogen bonding along with the effect of steric and electrostatic properties revealed by CoMFA. Conclusion The two 3D-QSAR model have demonstrated a good fit, the analysis of CoMFA and CoMSIA contour maps provided insight into the possible modification of the molecules with better activity.
出处 《中国药物化学杂志》 CAS CSCD 2007年第6期348-353,共6页 Chinese Journal of Medicinal Chemistry
基金 The national natural science foundation of China(30572239) The specialized research fund for the doctoralprogram of higher education(20050335045) The foundation of science and technology department of Zhejiang province ofChina(z303835)
关键词 2-苯氧茚酮类衍生物 乙酰胆碱酯酶抑制活性 三维构效关系 2-phenoxy-indan-1-one derivatives AChE inhibitory activity 3D-QSAR
  • 相关文献

参考文献1

二级参考文献4

  • 1Cheng D H,Pharmacol Biochem Behav,1998年,61卷
  • 2Cheng D H,Neuroreport,1996年,8卷,97页
  • 3席烯灿,中国药理学报,1996年,17卷,481页
  • 4Laganiere S,Neuropharmacology,1991年,30卷,763页

共引文献19

同被引文献26

  • 1邹磊,全明海,程永强,李里特.乙酰胆碱酯酶抑制剂的研究进展[J].食品科学,2005,26(z1):105-108. 被引量:25
  • 2朱兴族.阿尔采末症的药物治疗[J].中国处方药,2005,4(1):10-15. 被引量:2
  • 3盛一珉.乙酰胆碱酯酶抑制剂治疗老年痴呆的研究进展[J].浙江实用医学,2005,10(4):286-288. 被引量:7
  • 4杨晓军,刘锐军,李奇峰,张炳火,赵雪萍,文孟良.乙酰胆碱酯酶抑制剂研究现状[J].长江大学学报(自然科学版),2005,2(5):49-51. 被引量:6
  • 5曲方,刘宝印.老年痴呆病的药物治疗[J].中国实用乡村医生杂志,2006,13(10):4-6. 被引量:3
  • 6HARDY J, SELKOE D J. The amyloid hypothesis of Alzheimer' s disease: progress and problems on the road to therapeutics [J]. Science, 2002, 297 ( 5580 ) : 353 - 356.
  • 7SHAJI K S, SMITHA K, LAL K P, et al. Caregivers of people with Alzheimer's disease: a qualitative study from the Indian 10/66 dementia research network [J]. Int J Geriatr Psych, 2003, 18(1) :1 - 5.
  • 8GUPTA R C. Toxicology of organophosphate & carbamate compounds [ M ]. Frankfurt: Elsevier Press, 2006: 347 - 360.
  • 9RIOS J C, REPETTO G, GALLEGUILLOS I, et al. High concentrations of pralidoxime are needed for the adequate reactivation of human erythrocyte acetyl-cholinesterase inhibited by dimethoate in vitro [J]. Toxicol in Vitro, 2005,19(7) :893 - 897.
  • 10MUDD J B, DAWSON P J, ADAMS J R, et al. Reaction of ozone with enzymes of erythroeyte membranes [J]. Arch Bioehem Biophys, 1996, 335 ( 1 ) : 145 - 151.

引证文献4

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部